STOCK TITAN

NCV.PRA Stock Price, News & Analysis

NCV.PRA NYSE

Welcome to our dedicated page for NCV.PRA news (Ticker: NCV.PRA), a resource for investors and traders seeking the latest updates and insights on NCV.PRA stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NCV.PRA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NCV.PRA's position in the market.

Rhea-AI Summary

Virtus Convertible & Income Fund (NYSE: NCV) has declared a cash distribution of $0.3515625 per share for its Series A cumulative preferred shareholders. The distribution is payable on December 30, 2022, to shareholders of record by December 12, 2022. These preferred shares, rated 'A' by Fitch, have an annual dividend rate of $1.40625 and were issued at $25.00 per share. The shares will be callable after the non-call period ends on September 20, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Virtus AllianzGI Convertible & Income Fund (NCV) declared a cash distribution of $0.3515625 per share for Series A cumulative preferred shareholders, payable on June 30, 2022. Shareholders of record on June 13, 2022 will receive this payment. The Series A shares, trading under NCV.PRA, are rated 'A' by Fitch Ratings and have an annual dividend rate of $1.40625 per share. These shares were issued at $25.00 per share and are callable post a five-year non-call period ending September 20, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Virtus AllianzGI Convertible & Income Fund (NYSE: NCV) has declared a cash distribution of $0.3515625 per share for its Series A cumulative preferred shareholders, payable on March 31, 2022. Shareholders of record by March 11, 2022 will receive this payment, representing earnings accrued from January 1, 2022 to March 31, 2022. The fund's preferred shares, rated 'A' by Fitch Ratings, have an annual dividend rate of $1.40625 per share. Following a non-call period until September 20, 2023, shares can be called at their liquidation value of $25.00.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Virtus AllianzGI Convertible & Income Fund (NYSE: NCV) announced a cash distribution of $0.3515625 per share for Series A cumulative preferred shareholders, payable on September 30, 2021. The record date for this payment is September 13, 2021. The Series A shares, rated 'A' by Fitch, have an annual dividend rate of $1.40625 and were issued at $25.00 per share. Additionally, these shares will be callable after a five-year period ending September 20, 2023. Distributions' actual amounts may vary based on the fund's investment performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Virtus AllianzGI Convertible & Income Fund (NCV) has declared a cash distribution of $0.3515625 per share, payable on June 30, 2021, to Series A preferred shareholders recorded on June 11, 2021. The Series A shares, rated 'A' by Fitch, have an annual dividend rate of $1.40625 per share and were initially issued at $25.00 per share. The distribution covers the accrual period from April 1, 2021, to June 30, 2021. Furthermore, these shares become callable after the non-call period ends on September 20, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
NCV.PRA

NYSE:NCV.PRA

NCV.PRA Rankings

NCV.PRA Stock Data